Big Pharma and drug middlemen donated record money to get Trump on their side
In the months after the 2024 election and before President Donald Trump’s second inauguration, healthcare executives paid ...
Drug Middlemen Lose Bid to Block FTC Case on Insulin Cost (1)
A federal judge in Missouri rejected three major pharmacy benefit managers’ push to pause the Federal Trade Commission’s ...
Morningstar8d
CVS says blaming drug middlemen for higher prices is 'deceptive rhetoric'
Chief Executive David Joyner spent a lot of time on the post-earnings call with analysts defending PBMs, or what critics have called "drug middlemen." CVS is a PBM through its CVS Caremark business.
Pharmacy benefit management unicorn Capital Rx hits $3.5 billion in revenue with a different approach to drug pricing as Congress targets middlemen
Healthcare startup Capital Rx seeing revenue surge as Congress seeks to regulate the PBM giants that profit from high drug ...
Orange County Register8d
California Democrats clash over how to rein in drug industry middlemen
Gov. Gavin Newsom and state legislators in Sacramento seem to agree: Prescription drug prices are too high. But lawmakers and the second-term governor are at odds over what to do about it ...
Trump is unlikely to end Medicare drug price talks — here's what that means for patients and pharma
Trump could either weaken the negotiations in a way that benefits the pharmaceutical industry, or try to achieve even deeper ...
MarketWatch5d
CVS’s stock is having its best day since 1999, after more than just earnings
Investors also seemed to appreciate that Chief Executive David Joyner spent a lot of time on the post-earnings call with analysts defending PBMs, or what critics have called “drug middlemen.” ...
Alabama lawmakers consider bill some say will raise prescription prices
Alabamians could start paying more for their prescriptions. Lawmakers are considering a bill they said could help save rural ...
Morningstar8d
CVS's stock is having its best day since 1999, after more than just earnings
CVS says blaming drug middlemen for higher prices is 'deceptive rhetoric,' as PBMs have an 'unequivocal mechanism' to fight for lower drug prices Shares of CVS Health Corp. were having their best ...